Skip to main content

Heart Failure REDEFINE-HF

Status: Open to Enrollment
Email us to enroll

Study details

View study details on clinicaltrials.gov.

Locations

  • Sacramento

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.

This is an international, randomized, double-blind, placebo-controlled, event-driven trial of finerenone for the treatment hospitalized heart failure patients with mildly reduced or preserved ejection fraction.

Gurpreet S Sodhi, M.D.
Gurpreet S Sodhi, M.D.
Principal investigator
View profile

Sub-Investigators

Michael A Gibson, M.D., Zijian Xu, M.D., Ph.D., FACC

Email us to enroll

Related clinical trials

View all clinical trials
  • Clinical trial

    Heart Failure - TEAM-HF

    Trial to Evaluate Safety and Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure

    Status: Open to Enrollment

  • Clinical trial

    Heart Failure COMET-HF

    A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients With Symptomatic Heart Failure With Severely Reduced Ejection Fraction (COMET-HF)

    Status: Open to Enrollment

  • Clinical trial

    Heart Failure CONFIRMATION-HF

    Combined Efficacy and Safety of an Early, Intensive, Management Strategy with Finerenone and SGLT2 Inhibitor in Patients Hospitalized with Heart Failure (CONFIRMATION-HF)

    Status: Open to Enrollment

  • Clinical trial

    Heart Failure FINALITY-HF

    A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)

    Status: Open to Enrollment

  • Clinical trial

    Heart Failure AIM HIGHer Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System CA_CP_340

    Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?